The present pregnant women living with hiv antiretroviral therapy coverage for pmtct in Rwanda is 98%, a decrease of 2% (-2.0%) compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Rwanda
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Rwanda
PMTCT antiretroviral therapy coverage
More indicators for Rwanda
Male unintentional poisoning
2.2
-0.1
(2019)
Female wasting in children
1.4%
-0.7%
(2020)
Female prevalence of HIV
0.9%
-0.1%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar18
+intl dollar2
(2021)
Birth registration
85.6%
+29.6%
(2020)
Contraceptive modern method prevalence
58.4%
+10.9%
(2020)
Rwanda PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 98% | -2% |
| 2021 | 100% | 0% |
| 2020 | 100% | 0% |
| 2019 | 100% | +8% |
| 2018 | 92% | +1% |
| 2017 | 91% | -6% |
| 2016 | 97% | -3% |
| 2015 | 100% | 0% |
| 2014 | 100% | 0% |
| 2013 | 100% | +3% |
| 2012 | 97% | -3% |
| 2011 | 100% | +30% |
| 2010 | 70% | +1% |
| 2009 | 69% | -11% |
| 2008 | 80% | +5% |
| 2007 | 75% | +12% |
| 2006 | 63% | +13% |
| 2005 | 50% | +15% |
| 2004 | 35% | +35% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |